Capital International Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,864
| Closed | -$529K | – | 441 |
|
|
2023
Q2 | $529K | Hold |
6,864
| – | – | ﹤0.01% | 430 |
|
|
2023
Q1 | $570K | Sell |
6,864
-3,646,943
| -100% | -$302M | ﹤0.01% | 429 |
|
|
2022
Q4 | $314M | Sell |
3,653,807
-932,078
| -20% | -$73.8M | 0.08% | 202 |
|
|
2022
Q3 | $283M | Buy |
4,585,885
+13,084
| +0.3% | +$825K | 0.08% | 212 |
|
|
2022
Q2 | $283M | Sell |
4,572,801
-1,285,963
| -22% | -$79.6M | 0.08% | 212 |
|
|
2022
Q1 | $348M | Sell |
5,858,764
-30,413,697
| -84% | -$1.94B | 0.08% | 212 |
|
|
2021
Q4 | $2.63B | Sell |
36,272,461
-3,177,699
| -8% | -$219M | 0.56% | 43 |
|
|
2021
Q3 | $2.76B | Buy |
39,450,160
+13,173
| +0% | +$925K | 0.63% | 34 |
|
|
2021
Q2 | $2.72B | Sell |
39,436,987
-593,224
| -1% | -$39.6M | 0.62% | 34 |
|
|
2021
Q1 | $2.59B | Sell |
40,030,211
-6,518,785
| -14% | -$420M | 0.65% | 35 |
|
|
2020
Q4 | $2.71B | Sell |
46,548,996
-1,984,981
| -4% | -$120M | 0.74% | 30 |
|
|
2020
Q3 | $3.07B | Sell |
48,533,977
-8,609,170
| -15% | -$597M | 0.95% | 18 |
|
|
2020
Q2 | $4.4B | Buy |
57,143,147
+773,490
| +1% | +$59.3M | 1.44% | 13 |
|
|
2020
Q1 | $4.21B | Buy |
56,369,657
+43,464,551
| +337% | +$3B | 1.72% | 14 |
|
|
2019
Q4 | $839M | Buy |
12,905,106
+575,721
| +5% | +$37.5M | 0.28% | 105 |
|
|
2019
Q3 | $781M | Buy |
12,329,385
+2,228,763
| +22% | +$146M | 0.3% | 97 |
|
|
2019
Q2 | $682M | Buy |
10,100,622
+2,049,862
| +25% | +$135M | 0.27% | 100 |
|
|
2019
Q1 | $523M | Sell |
8,050,760
-5,708,885
| -41% | -$379M | 0.22% | 113 |
|
|
2018
Q4 | $861M | Buy |
13,759,645
+8,203
| +0.1% | +$573K | 0.43% | 61 |
|
|
2018
Q3 | $1.06B | Sell |
13,751,442
-1,095,836
| -7% | -$82.8M | 0.49% | 57 |
|
|
2018
Q2 | $1.05B | Buy |
14,847,278
+7,150
| +0% | +$505K | 1.19% | 21 |
|
|
2018
Q1 | $1.12B | Buy |
14,840,128
+983,931
| +7% | +$78.2M | 1.29% | 17 |
|
|
2017
Q4 | $993M | Buy |
13,856,197
+2,639,182
| +24% | +$200M | 1.12% | 24 |
|
|
2017
Q3 | $909M | Buy |
11,217,015
+5,205,983
| +87% | +$398M | 1.09% | 25 |
|
|
2017
Q2 | $425M | Buy |
6,011,032
+982
| +0% | +$65.3K | 0.57% | 59 |
|
|
2017
Q1 | $408M | Buy |
6,010,050
+3,059,814
| +104% | +$215M | 0.55% | 59 |
|
|
2016
Q4 | $211M | Sell |
2,950,236
-396,290
| -12% | -$29.5M | 0.31% | 104 |
|
|
2016
Q3 | $265M | Sell |
3,346,526
-871,604
| -21% | -$70.8M | 0.38% | 82 |
|
|
2016
Q2 | $352M | Sell |
4,218,130
-707,225
| -14% | -$62.8M | 0.52% | 55 |
|
|
2016
Q1 | $452M | Buy |
4,925,355
+243
| +0% | +$21.9K | 0.69% | 42 |
|
|
2015
Q4 | $498M | Sell |
4,925,112
-416,282
| -8% | -$43.3M | 0.77% | 39 |
|
|
2015
Q3 | $524M | Sell |
5,341,394
-937,106
| -15% | -$104M | 0.95% | 27 |
|
|
2015
Q2 | $735M | Hold |
6,278,500
| – | – | 1.25% | 18 |
|
|
2015
Q1 | $616M | Sell |
6,278,500
-800,900
| -11% | -$81.3M | 1.12% | 20 |
|
|
2014
Q4 | $667M | Sell |
7,079,400
-2,240,700
| -24% | -$232M | 1.36% | 14 |
|
|
2014
Q3 | $992M | Sell |
9,320,100
-614,400
| -6% | -$60.2M | 2.42% | 3 |
|
|
2014
Q2 | $824M | Sell |
9,934,500
-494,300
| -5% | -$38.5M | 2.13% | 4 |
|
|
2014
Q1 | $739M | Buy |
10,428,800
+341,100
| +3% | +$26.8M | 1.99% | 4 |
|
|
2013
Q4 | $758M | Hold |
10,087,700
| – | – | 2.35% | 3 |
|
|
2013
Q3 | $634M | Sell |
10,087,700
-266,600
| -3% | -$15.9M | 2.71% | 1 |
|
|
2013
Q2 | $530M | Buy |
+10,354,300
| New | +$540M | 2.41% | 3 |
|
Other funds holding GILD
Capital International Investors's GILD Position: Q3 2023 in Review
Capital International Investors sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 6,864 shares — an estimated $529K sold.
Capital International Investors first reported a position in GILD in Q2 2013 and held it in 41 quarters. The position peaked at $4.4B in Q2 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- Capital International Investors reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
- Capital International Investors sold 6,864 Gilead Sciences shares in Q3 2023, an estimated $529K.
- Capital International Investors first reported a position in Gilead Sciences in Q2 2013 and held it in 41 quarters.
- Capital International Investors's Gilead Sciences position peaked at $4.4B in Q2 2020.
- 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on Capital International Investors's 13F filing for Q3 2023, filed 13 Nov 2023.